3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
4358
Neoplasms
3060
Prostatic Neoplasms
1904
Colorectal Neoplasms
1739
Lung Neoplasms
1557
Carcinoma, Non-Small-Cell Lung
1270
Pancreatic Neoplasms
981
Leukemia, Myeloid, Acute
952
Multiple Myeloma
951
Lymphoma
912
Head and Neck Neoplasms
894
Leukemia
852
Precursor Cell Lymphoblastic Leukemia-Lymphoma
833
Neoplasm Metastasis
794
Colonic Neoplasms
786
Carcinoma, Hepatocellular
762
Ovarian Neoplasms
758
Melanoma
752
Stomach Neoplasms
743
Rectal Neoplasms
701
Brain Neoplasms
699
Lymphoma, Non-Hodgkin
663
Leukemia, Lymphocytic, Chronic, B-Cell
618
Uterine Cervical Neoplasms
608
Lymphoma, Follicular
559
Glioblastoma
542
Recurrence
541
Hodgkin Disease
532
Esophageal Neoplasms
527
Myelodysplastic Syndromes
508
Interventions
abiraterone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
OTHER
×
Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy
×
Clear all
NCT01780220
2022-05-19
CARLHA
UNICANCER
Phase 1/2
Completed
47 enrolled